Report Detail
Global Cervical Cancer Diagnostic Testing Market Insights, Forecast to 2025
- RnM3447704 |
- 22 May, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Other
Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract.
North America accounted for the largest share of the global market, followed by Europe.
Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region.
The global Cervical Cancer Diagnostic Testing market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cervical Cancer Diagnostic Testing market based on company, product type, end user and key regions.
This report studies the global market size of Cervical Cancer Diagnostic Testing in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cervical Cancer Diagnostic Testing in these regions.
This research report categorizes the global Cervical Cancer Diagnostic Testing market by top players/brands, region, type and end user. This report also studies the global Cervical Cancer Diagnostic Testing market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
F. Hoffmann-La Roche
GlaxoSmithKline
Merck
Advaxis Immunotherapies
Bionor Pharma
Dendreon Corporation
Inovio Pharmaceuticals
ISA Pharmaceuticals
Otsuka Pharmaceuticals
Profectus Biosciences
Virometix
Hologic
Market size by Product
Pap Testing
HPV Testing
Colposcopy
Cervical Biopsies
Market size by End User
Hospitals
Cancer Palliative care clinics
Diagnostic centers
Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cervical Cancer Diagnostic Testing market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cervical Cancer Diagnostic Testing market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cervical Cancer Diagnostic Testing companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cervical Cancer Diagnostic Testing submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cervical Cancer Diagnostic Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cervical Cancer Diagnostic Testing market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cervical Cancer Diagnostic Testing Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cervical Cancer Diagnostic Testing Market Size Growth Rate by Product
- 1.4.2 Pap Testing
- 1.4.3 HPV Testing
- 1.4.4 Colposcopy
- 1.4.5 Cervical Biopsies
- 1.5 Market by End User
- 1.5.1 Global Cervical Cancer Diagnostic Testing Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Cancer Palliative care clinics
- 1.5.4 Diagnostic centers
- 1.5.5 Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cervical Cancer Diagnostic Testing Market Size
- 2.1.1 Global Cervical Cancer Diagnostic Testing Revenue 2014-2025
- 2.1.2 Global Cervical Cancer Diagnostic Testing Sales 2014-2025
- 2.2 Cervical Cancer Diagnostic Testing Growth Rate by Regions
- 2.2.1 Global Cervical Cancer Diagnostic Testing Sales by Regions
- 2.2.2 Global Cervical Cancer Diagnostic Testing Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cervical Cancer Diagnostic Testing Sales by Manufacturers
- 3.1.1 Cervical Cancer Diagnostic Testing Sales by Manufacturers
- 3.1.2 Cervical Cancer Diagnostic Testing Sales Market Share by Manufacturers
- 3.1.3 Global Cervical Cancer Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
- 3.2 Cervical Cancer Diagnostic Testing Revenue by Manufacturers
- 3.2.1 Cervical Cancer Diagnostic Testing Revenue by Manufacturers (2014-2019)
- 3.2.2 Cervical Cancer Diagnostic Testing Revenue Share by Manufacturers (2014-2019)
- 3.3 Cervical Cancer Diagnostic Testing Price by Manufacturers
- 3.4 Cervical Cancer Diagnostic Testing Manufacturing Base Distribution, Product Types
- 3.4.1 Cervical Cancer Diagnostic Testing Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cervical Cancer Diagnostic Testing Product Type
- 3.4.3 Date of International Manufacturers Enter into Cervical Cancer Diagnostic Testing Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cervical Cancer Diagnostic Testing Sales by Product
- 4.2 Global Cervical Cancer Diagnostic Testing Revenue by Product
- 4.3 Cervical Cancer Diagnostic Testing Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cervical Cancer Diagnostic Testing Breakdown Data by End User
6 North America
- 6.1 North America Cervical Cancer Diagnostic Testing by Countries
- 6.1.1 North America Cervical Cancer Diagnostic Testing Sales by Countries
- 6.1.2 North America Cervical Cancer Diagnostic Testing Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cervical Cancer Diagnostic Testing by Product
- 6.3 North America Cervical Cancer Diagnostic Testing by End User
7 Europe
- 7.1 Europe Cervical Cancer Diagnostic Testing by Countries
- 7.1.1 Europe Cervical Cancer Diagnostic Testing Sales by Countries
- 7.1.2 Europe Cervical Cancer Diagnostic Testing Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cervical Cancer Diagnostic Testing by Product
- 7.3 Europe Cervical Cancer Diagnostic Testing by End User
8 Asia Pacific
- 8.1 Asia Pacific Cervical Cancer Diagnostic Testing by Countries
- 8.1.1 Asia Pacific Cervical Cancer Diagnostic Testing Sales by Countries
- 8.1.2 Asia Pacific Cervical Cancer Diagnostic Testing Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cervical Cancer Diagnostic Testing by Product
- 8.3 Asia Pacific Cervical Cancer Diagnostic Testing by End User
9 Central & South America
- 9.1 Central & South America Cervical Cancer Diagnostic Testing by Countries
- 9.1.1 Central & South America Cervical Cancer Diagnostic Testing Sales by Countries
- 9.1.2 Central & South America Cervical Cancer Diagnostic Testing Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cervical Cancer Diagnostic Testing by Product
- 9.3 Central & South America Cervical Cancer Diagnostic Testing by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cervical Cancer Diagnostic Testing by Countries
- 10.1.1 Middle East and Africa Cervical Cancer Diagnostic Testing Sales by Countries
- 10.1.2 Middle East and Africa Cervical Cancer Diagnostic Testing Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cervical Cancer Diagnostic Testing by Product
- 10.3 Middle East and Africa Cervical Cancer Diagnostic Testing by End User
11 Company Profiles
- 11.1 F. Hoffmann-La Roche
- 11.1.1 F. Hoffmann-La Roche Company Details
- 11.1.2 Company Business Overview
- 11.1.3 F. Hoffmann-La Roche Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 F. Hoffmann-La Roche Cervical Cancer Diagnostic Testing Products Offered
- 11.1.5 F. Hoffmann-La Roche Recent Development
- 11.2 GlaxoSmithKline
- 11.2.1 GlaxoSmithKline Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GlaxoSmithKline Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GlaxoSmithKline Cervical Cancer Diagnostic Testing Products Offered
- 11.2.5 GlaxoSmithKline Recent Development
- 11.3 Merck
- 11.3.1 Merck Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merck Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merck Cervical Cancer Diagnostic Testing Products Offered
- 11.3.5 Merck Recent Development
- 11.4 Advaxis Immunotherapies
- 11.4.1 Advaxis Immunotherapies Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Products Offered
- 11.4.5 Advaxis Immunotherapies Recent Development
- 11.5 Bionor Pharma
- 11.5.1 Bionor Pharma Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bionor Pharma Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bionor Pharma Cervical Cancer Diagnostic Testing Products Offered
- 11.5.5 Bionor Pharma Recent Development
- 11.6 Dendreon Corporation
- 11.6.1 Dendreon Corporation Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Dendreon Corporation Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Dendreon Corporation Cervical Cancer Diagnostic Testing Products Offered
- 11.6.5 Dendreon Corporation Recent Development
- 11.7 Inovio Pharmaceuticals
- 11.7.1 Inovio Pharmaceuticals Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Products Offered
- 11.7.5 Inovio Pharmaceuticals Recent Development
- 11.8 ISA Pharmaceuticals
- 11.8.1 ISA Pharmaceuticals Company Details
- 11.8.2 Company Business Overview
- 11.8.3 ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Products Offered
- 11.8.5 ISA Pharmaceuticals Recent Development
- 11.9 Otsuka Pharmaceuticals
- 11.9.1 Otsuka Pharmaceuticals Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Products Offered
- 11.9.5 Otsuka Pharmaceuticals Recent Development
- 11.10 Profectus Biosciences
- 11.10.1 Profectus Biosciences Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Profectus Biosciences Cervical Cancer Diagnostic Testing Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Profectus Biosciences Cervical Cancer Diagnostic Testing Products Offered
- 11.10.5 Profectus Biosciences Recent Development
- 11.11 Virometix
- 11.12 Hologic
12 Future Forecast
- 12.1 Cervical Cancer Diagnostic Testing Market Forecast by Regions
- 12.1.1 Global Cervical Cancer Diagnostic Testing Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cervical Cancer Diagnostic Testing Revenue Forecast by Regions 2019-2025
- 12.2 Cervical Cancer Diagnostic Testing Market Forecast by Product
- 12.2.1 Global Cervical Cancer Diagnostic Testing Sales Forecast by Product 2019-2025
- 12.2.2 Global Cervical Cancer Diagnostic Testing Revenue Forecast by Product 2019-2025
- 12.3 Cervical Cancer Diagnostic Testing Market Forecast by End User
- 12.4 North America Cervical Cancer Diagnostic Testing Forecast
- 12.5 Europe Cervical Cancer Diagnostic Testing Forecast
- 12.6 Asia Pacific Cervical Cancer Diagnostic Testing Forecast
- 12.7 Central & South America Cervical Cancer Diagnostic Testing Forecast
- 12.8 Middle East and Africa Cervical Cancer Diagnostic Testing Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cervical Cancer Diagnostic Testing Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cervical Cancer Diagnostic Testing . Industry analysis & Market Report on Cervical Cancer Diagnostic Testing is a syndicated market report, published as Global Cervical Cancer Diagnostic Testing Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cervical Cancer Diagnostic Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
